Global Scaffold Technology Market is set to expand at a CAGR of 11.3% until 2034 | Future Market Insights, Inc. [Yahoo! Finance]
Bioventus Inc. - Class A (BVS)
Company Research
Source: Yahoo! Finance
As these fields develop, demand for innovative scaffold materials to aid tissue repair and regeneration is expected to soar. This highlights the crucial role scaffold technology plays in revolutionizing healthcare and paving the way for personalized regenerative medicine solutions. NEWARK, Del. April 30, 2024 /PRNewswire/ -- The scaffold technology industry is expected to be valued at US$ 1,490.7 million by 2024 . The market valuation is estimated to be US$ 4,348.6 million by 2034 , projected at a CAGR of 11.3%. Download the Sample PDF report to explore key market insights and trends: https://www.futuremarketinsights.com/reports/sample/rep-gb-16020 The scaffold technology industry is propelled by advancements in tissue engineering and regenerative medicine technologies that augment demand for scaffold materials. The aging population and rising healthcare costs are driving demand for tissue regeneration techniques. The surge in investments in research and development activities
Show less
Read more
Impact Snapshot
Event Time:
BVS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BVS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BVS alerts
High impacting Bioventus Inc. - Class A news events
Weekly update
A roundup of the hottest topics
BVS
News
- Bioventus Inc. (NYSE: BVS) had its price target raised by analysts at Canaccord Genuity Group Inc. from $7.00 to $8.00. They now have a "buy" rating on the stock.MarketBeat
- Bioventus Inc. (NASDAQ:BVS) Q1 2024 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- Bioventus Reports First Quarter Financial Results [Yahoo! Finance]Yahoo! Finance
- Bioventus Reports First Quarter Financial ResultsGlobeNewswire
- Osteoarthritis Market Forecast Reveals Significant Growth and Upcoming Therapeutic Advancements by 2032 [Yahoo! Finance]Yahoo! Finance
BVS
Earnings
- 5/7/24 - Beat
BVS
Sec Filings
- 5/7/24 - Form 10-Q
- 5/7/24 - Form 8-K
- 4/26/24 - Form ARS
- BVS's page on the SEC website